“We are trying to maintain patient programs, but we need funding to do it and that is why the walk is so important," said ...

HealthDay News — For patients with systemic lupus erythematosus (SLE) and pericarditis, recurrence of pericarditis occurs in more than 20 percent of patients and associated factors include younger age ...

In standing together, we can ensure that Mercédi’s fight with lupus is not her fight alone. A community mobilised by empathy ...

The drug in question is cenerimod, a S1P1 receptor modulator currently in phase 3 trials for systemic lupus erythematosus (SLE). The latest licensing deal forms part of a broader restructuring of ...

BACKGROUND: Statins have been increasingly associated with drug-induced autoimmune reactions, including lupus erythematosus. OBJECTIVE: To identify and determine the clinical and biological ...

The following is a summary of “Dual seropositive nonerosive lupus arthritis: rhupus or not?” published in the February 2025 issue of Advances in Rheumatology by Pekdiker & Kara. Researchers conducted ...

Systemic lupus erythematosus (SLE) is a chronic autoimmune condition that causes widespread inflammation. It can affect the skin, joints, blood vessels, and multiple organ systems. The exact cause ...

The U.S. Food and Drug Administration (FDA) approved anifrolumab in 2021 for treatment of systemic lupus erythematosus, the most common form of lupus. Anifrolumab Is a monoclonal antibody that works ...

The U.S. Food and Drug Administration (FDA) approved anifrolumab in 2021 for treatment of systemic lupus erythematosus, the most common form of lupus. Anifolumab Is a monoclonal antibody that ...